Oppenheimer Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $693K | Buy |
|
|||||
|
2025
Q1 | $686K | Buy |
|
|||||
|
2024
Q4 | $892K | Buy |
|
|||||
|
2024
Q3 | $893K | Sell |
|
|||||
|
2024
Q2 | $743K | Buy |
|
|||||
|
2024
Q1 | $786K | Sell |
|
|||||
|
2023
Q4 | $851K | Sell |
|
|||||
|
2023
Q3 | $1.18M | Hold |
|
|||||
|
2023
Q2 | $1.25M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Buy |
|
|||||
|
2022
Q4 | $961K | Buy |
|
|||||
|
2022
Q3 | $638K | Buy |
|
|||||
|
2022
Q2 | $737K | Sell |
|
|||||
|
2022
Q1 | $853K | Sell |
|
|||||
|
2021
Q4 | $1.65M | Sell |
|
|||||
|
2021
Q3 | $1.98M | Buy |
|
|||||
|
2021
Q2 | $1.69M | Buy |
|
|||||
|
2021
Q1 | $1.48M | Buy |
|
|||||
|
2020
Q4 | $1.32M | Sell |
|
|||||
|
2020
Q3 | $1.18M | Sell |
|
|||||
|
2020
Q2 | $1.29M | Sell |
|
|||||
|
2020
Q1 | $1.05M | Sell |
|
|||||
|
2019
Q4 | $1.27M | Hold |
|
|||||
|
2019
Q3 | $1.14M | Sell |
|
|||||
|
2019
Q2 | $1.14M | Sell |
|
|||||
|
2019
Q1 | $1.14M | Buy |
|
|||||
|
2018
Q4 | $673K | Sell |
|
|||||
|
2018
Q3 | $1.08M | Buy |
|
|||||
|
2018
Q2 | $475K | Sell |
|
|||||
|
2018
Q1 | $424K | Sell |
|
|||||
|
2017
Q4 | $406K | Hold |
|
|||||
|
2017
Q3 | $406K | Sell |
|
|||||
|
2017
Q2 | $418K | Sell |
|
|||||
|
2017
Q1 | $428K | Buy |
|